Collegium Pharmaceutical, Inc. Maturities of Senior Debt
Collegium Pharmaceutical, Inc. (COLL) reported Maturities of Senior Debt of $2.67 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:MaturitiesOfSeniorDebt · last filed 2017-03-10
- Collegium Pharmaceutical, Inc. maturities of senior debt for the quarter ending 2016-12-31 was $667.00K, a 0.00% change year-over-year.
- Collegium Pharmaceutical, Inc. maturities of senior debt for the quarter ending 2016-09-30 was $667.00K, a 165.74% increase year-over-year.
- Collegium Pharmaceutical, Inc. maturities of senior debt for the quarter ending 2016-06-30 was $666.00K, a 301.20% increase year-over-year.
- Collegium Pharmaceutical, Inc. maturities of senior debt for the quarter ending 2016-03-31 was $667.00K, a 230.20% increase year-over-year.
- Collegium Pharmaceutical, Inc. maturities of senior debt for fiscal 2016 was $2.67M, a 107.39% increase from fiscal 2015.
- Collegium Pharmaceutical, Inc. maturities of senior debt for fiscal 2015 was $1.29M, a 4492.86% increase from fiscal 2014.
- Collegium Pharmaceutical, Inc. maturities of senior debt for fiscal 2014 was $28.00K, a 34.88% decline from fiscal 2013.
- Collegium Pharmaceutical, Inc. maturities of senior debt for fiscal 2013 was $43.00K.
| Period end | Maturities of Senior Debt 3 month | Maturities of Senior Debt 6 month | Maturities of Senior Debt 9 month | Maturities of Senior Debt 12 month |
|---|---|---|---|---|
| 2016-12-31 | $667.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $1.33M derived: sum of 2 quarters · filed 2017-03-10 | $2.00M derived: sum of 3 quarters · filed 2017-03-10 | $2.67M 10-K · filed 2017-03-10 |
| 2016-09-30 | $667.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $1.33M derived: sum of 2 quarters · filed 2016-11-10 | $2.00M 10-Q · filed 2016-11-10 | $2.67M derived: sum of 4 quarters · filed 2017-03-10 |
| 2016-06-30 | $666.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $1.33M 10-Q · filed 2016-08-11 | $2.00M derived: sum of 3 quarters · filed 2017-03-10 | $2.25M derived: sum of 4 quarters · filed 2017-03-10 |
| 2016-03-31 | $667.00K 10-Q · filed 2016-05-11 | $1.33M derived: sum of 2 quarters · filed 2017-03-10 | $1.58M derived: sum of 3 quarters · filed 2017-03-10 | $1.75M derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-12-31 | $667.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $918.00K derived: sum of 2 quarters · filed 2017-03-10 | $1.08M derived: sum of 3 quarters · filed 2017-03-10 | $1.29M 10-K · filed 2017-03-10 |
| 2015-09-30 | $251.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $417.00K derived: sum of 2 quarters · filed 2016-11-10 | $619.00K 10-Q · filed 2016-11-10 | $7.69M derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-06-30 | $166.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $368.00K 10-Q · filed 2016-08-11 | $7.44M derived: sum of 3 quarters · filed 2017-03-10 | |
| 2015-03-31 | $202.00K 10-Q · filed 2016-05-11 | $7.27M derived: sum of 2 quarters · filed 2017-03-10 | ||
| 2014-12-31 | $7.07M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $28.00K 10-K · filed 2017-03-10 | ||
| 2014-09-30 | -$7.04M 10-Q · filed 2015-11-12 | |||
| 2013-12-31 | $43.00K 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |